SCHEMBL14537229

SCHEMBL14537229

B[C@@H]1O[C@H](COC)[C@@H](OC)[C@H]1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22317545 1.00 — —
SCHEMBL14295971 1.00 — —
SCHEMBL16943046 0.85 — —
SCHEMBL26652153 0.82 FGF1 (0.33) —
SCHEMBL10310995 0.82 FGF1 (0.33) —
SCHEMBL13222901 0.82 FGF1 (0.33) —
SCHEMBL12253802 0.82 FGF1 (0.33) —
SCHEMBL10001262 0.82 FGF1 (0.33) —
SCHEMBL20329200 0.82 — —
SCHEMBL26474211 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070123702-A1 Oligonucleotdies having A-DNA form and B-DNA form conformational geometry MANOHARAN MUTHIAH 2007-05-31 — — US disclosed
EP-1743901-A2 Oligonucleotides having A-DNA or B-DNA form ISIS PHARMACEUTICALS, INC. (US) 2007-01-17 — — EP disclosed
Send feedback